Cite

HARVARD Citation

    Lyden, S. et al. (2022). No Mortality Signal With Stellarex Low-Dose Paclitaxel DCB: ILLUMENATE Pivotal 4-Year Outcomes. Journal of endovascular therapy. pp. 929-936. [Online]. 
  
Back to record